Kakkalide

CAS No. 58274-56-9

Kakkalide( —— )

Catalog No. M24574 CAS No. 58274-56-9

Kakkalide is a potent lactate dehydrogenase (LDH) inhibitor, it has anti-inflammatory effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 396 In Stock
10MG 591 In Stock
25MG 942 In Stock
50MG 1237 In Stock
100MG 1655 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Kakkalide
  • Note
    Research use only, not for human use.
  • Brief Description
    Kakkalide is a potent lactate dehydrogenase (LDH) inhibitor, it has anti-inflammatory effects.
  • Description
    Kakkalide is a potent lactate dehydrogenase (LDH) inhibitor, it has anti-inflammatory effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    LDH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58274-56-9
  • Formula Weight
    608.6
  • Molecular Formula
    C28H32O15
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C1C2=C(O)C(OC)=C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO[C@H]4[C@@H]([C@H]([C@H](O)CO4)O)O)C=C2OC=C1C5=CC=C(OC)C=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kakkalide ameliorates endothelial insulin resistance by suppressing reactive oxygen species-associated inflammation.J Diabetes. 2013 Mar;5(1):13-24.
molnova catalog
related products
  • GSK864

    GSK864 is an IDH1 mutant inhibitor that inhibits IDH1 mutants R132C, R132H, and R132G, and is used in the study of cardiovascular and oncology diseases.

  • ASLAN003

    ASLAN003 is an orally active and potent inhibitor of DHODH (Human Dihydroorotate Dehydrogenase) with antitumor activity. It has the potential to be a first-in-class candidate in AML.

  • AGI-6780

    AGI-6780 is a potent and selective inhibitor of IDH2 R140Q mutant with IC50 of 23 nM.